Avalyn Pharma
Clinical-stage biopharma developing inhaled drugs for rare lung diseases such as pulmonary fibrosis
Highlights
- New on EvolcAdded 2026-11-13
About Avalyn Pharma
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines for rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. Its approach is to deliver formulations of established medicines directly to lung tissue, with the aim of improving efficacy and avoiding side effects associated with systemic drug delivery.
Its pipeline includes two clinical-stage programs, AP01 (inhaled pirfenidone) and AP02 (inhaled nintedanib), and a preclinical program, AP03, a fixed-dose combination of inhaled pirfenidone and nintedanib. The target patients are people with pulmonary fibrosis and other interstitial lung diseases.
The company is listed on NASDAQ (AVLN) after a 2026 IPO and reports raising more than $620 million from investors. Its CEO is Lyn Baranowski. Open roles are listed in Boston, MA and in remote positions in the United States, mainly in regulatory affairs, clinical development, CMC technical writing, supply chain and business operations. The company is certified as a Great Place To Work.
Product: Inhaled drug candidates: AP01 (inhaled pirfenidone) and AP02 (inhaled nintedanib) in clinical stage; AP03 (inhaled combination) preclinical.
Jobs at Avalyn Pharma
More biotech & pharma companies
Axsome Therapeutics
Biopharma developing prescription medicines for psychiatric and neurologic brain disorders such as depression and migraineGrowingBeeline Medicines
Clinical-stage biotech developing precision therapies for autoimmune and inflammatory diseases, led by a lupus candidateNew on EvolcSalary transparentBeigene
Oncology medicines research and development for patients and healthcare systems worldwideRemote-friendlySalary transparentBiocryst
Develops medicines for hereditary angioedema and other rare diseases for patients with unmet treatment needsNew on EvolcBiocytogen
Drug discovery platforms, animal models and preclinical research services for pharmaceutical and biotechnology companiesNew on EvolcBluerocktx
Develops cell therapies for patients with degenerative diseases, including neurology and ophthalmology conditionsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Contact Form 7High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Recruiting
- GreenhouseHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.